enGene Holdings Inc. — Investor Relations & Filings
enGene Holdings Inc. is a clinical-stage biotechnology company developing non-viral gene therapies. The company's proprietary platform is designed for the local delivery of DNA-based immunotherapies directly to mucosal tissues and other organs. Its lead product candidate, EG-70 (detalimogene voraplasmid), is an intravesical therapy being evaluated for the treatment of high-risk, BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The therapeutic approach aims to stimulate a patient's own immune system to attack tumor cells. By avoiding viral vectors, enGene seeks to create re-dosable genetic medicines that can be administered without the complexities and potential immunogenicity associated with viral-based systems, with the goal of making gene-based treatments more accessible.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - enGene Therapeutics Inc. (0001980845) (Filer) | 2026-05-07 | English | |
| 8-K - enGene Therapeutics Inc. (0001980845) (Filer) | 2026-04-09 | English | |
| S-3 - ENGENE HOLDINGS INC. (0001980845) (Filer) | 2026-02-19 | English | |
| 10-K/A - ENGENE HOLDINGS INC. (0001980845) (Filer) | 2026-02-19 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42868120 | 8-K - enGene Therapeutics Inc. (0001980845) (Filer) | 2026-05-07 | English | ||
| 33934986 | 8-K - enGene Therapeutics Inc. (0001980845) (Filer) | 2026-04-09 | English | ||
| 32900837 | S-3 - ENGENE HOLDINGS INC. (0001980845) (Filer) | 2026-02-19 | English | ||
| 32900836 | 10-K/A - ENGENE HOLDINGS INC. (0001980845) (Filer) | 2026-02-19 | English | ||
| 32274886 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 32274884 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32274835 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32274946 | 4 Filing | 2026-02-03 | English | ||
| 32274937 | 4 Filing | 2026-02-03 | English | ||
| 32274933 | 4 Filing | 2026-02-03 | English | ||
| 32274932 | 4 Filing | 2026-02-03 | English | ||
| 32274917 | 4 Filing | 2026-02-03 | English | ||
| 32274909 | 4 Filing | 2026-02-03 | English | ||
| 32274904 | 4 Filing | 2026-02-03 | English | ||
| 32274832 | 4 Filing | 2026-02-03 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ARGENT BIOPHARMA LIMITED
Develops plant-inspired and synthetic medicines for neurolo…
|
RGT | AU | Manufacturing |
|
argenx SE
Develops and commercializes antibody-based therapies for se…
|
1AE | NL | Manufacturing |
|
Armata Pharmaceuticals, Inc.
Develops bacteriophage therapeutics for antibiotic-resistan…
|
ARMP | US | Manufacturing |
|
AroCell AB
Develops and markets in vitro diagnostic (IVD) tests for on…
|
AROC | SE | Manufacturing |
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
|
ARROWHEAD PHARMACEUTICALS, INC.
Biotechnology company developing RNAi therapies to treat in…
|
ARWR | US | Manufacturing |
|
ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for admini…
|
SPRY | US | Manufacturing |
|
ARTELO BIOSCIENCES, INC.
Clinical-stage biopharma developing therapeutics by modulat…
|
ARTL | US | Manufacturing |
|
Arura Pharma Inc
Diversified manufacturer and distributor in consumer goods …
|
— | CA | Manufacturing |
|
Ascelia Pharma
Biotechnology company developing and commercializing novel …
|
ACE | SE | Manufacturing |
enGene Holdings Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33225/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33225 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33225 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33225 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33225}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for enGene Holdings Inc. (id: 33225)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.